Literature DB >> 18259216

The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing.

Markus Haindl1, Thomas Harasim, Dirk Eick, Stefan Muller.   

Abstract

The ubiquitin-like SUMO system functions by a cyclic process of modification and demodification, and recent data suggest that the nucleolus is a site of sumoylation-desumoylation cycles. For example, the tumour suppressor ARF stimulates sumoylation of nucleolar proteins. Here, we show that the nucleolar SUMO-specific protease SENP3 is associated with nucleophosmin (NPM1), a crucial factor in ribosome biogenesis. SENP3 catalyses desumoylation of NPM1-SUMO2 conjugates in vitro and counteracts ARF-induced modification of NPM1 by SUMO2 in vivo. Intriguingly, depletion of SENP3 by short interfering RNA interferes with nucleolar ribosomal RNA processing and inhibits the conversion of the 32S rRNA species to the 28S form, thus phenocopying the processing defect observed on depletion of NPM1. Moreover, mimicking constitutive modification of NPM1 by SUMO2 interferes with 28S rRNA maturation. These results define SENP3 as an essential factor for ribosome biogenesis and suggest that deconjugation of SUMO2 from NPM1 by SENP3 is critically involved in 28S rRNA maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259216      PMCID: PMC2267381          DOI: 10.1038/embor.2008.3

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  31 in total

1.  Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein.

Authors:  Yin-Yuan Mo; Yanni Yu; Zhiyuan Shen; William T Beck
Journal:  J Biol Chem       Date:  2001-11-14       Impact factor: 5.157

2.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.

Authors:  Darja Schmidt; Stefan Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

3.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

Authors:  Koji Itahana; Krishna P Bhat; Aiwen Jin; Yoko Itahana; David Hawke; Ryuji Kobayashi; Yanping Zhang
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

Review 4.  PIAS/SUMO: new partners in transcriptional regulation.

Authors:  D Schmidt; S Müller
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

5.  In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.

Authors:  Noriko Saitoh; Yasuhiro Uchimura; Taro Tachibana; Satoko Sugahara; Hisato Saitoh; Mitsuyoshi Nakao
Journal:  Exp Cell Res       Date:  2006-05-01       Impact factor: 3.905

6.  Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.

Authors:  Masataka Sugimoto; Mei-Ling Kuo; Martine F Roussel; Charles J Sherr
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

7.  The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Authors:  Andrea Pichler; Andreas Gast; Jacob S Seeler; Anne Dejean; Frauke Melchior
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

8.  P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2.

Authors:  Dimitris P Xirodimas; June Chisholm; Joana M S Desterro; David P Lane; Ronald T Hay
Journal:  FEBS Lett       Date:  2002-09-25       Impact factor: 4.124

9.  c-Jun and p53 activity is modulated by SUMO-1 modification.

Authors:  S Muller; M Berger; F Lehembre; J S Seeler; Y Haupt; A Dejean
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

10.  MDM2-ARF complex regulates p53 sumoylation.

Authors:  Lihong Chen; Jiandong Chen
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

View more
  69 in total

1.  Las1L is a nucleolar protein required for cell proliferation and ribosome biogenesis.

Authors:  Christopher D Castle; Erica K Cassimere; Jinho Lee; Catherine Denicourt
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

Review 2.  Nucleolar targeting: the hub of the matter.

Authors:  Edward Emmott; Julian A Hiscox
Journal:  EMBO Rep       Date:  2009-02-20       Impact factor: 8.807

3.  RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.

Authors:  Ulf R Klein; Markus Haindl; Erich A Nigg; Stefan Muller
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

Review 4.  SUMOylation and De-SUMOylation: wrestling with life's processes.

Authors:  Edward T H Yeh
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 5.  The SUMO system: a master organizer of nuclear protein assemblies.

Authors:  Nithya Raman; Arnab Nayak; Stefan Muller
Journal:  Chromosoma       Date:  2013-08-06       Impact factor: 4.316

Review 6.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

7.  Phosphatidylinositol-4-phosphate 5-Kinase 1α Modulates Ribosomal RNA Gene Silencing through Its Interaction with Histone H3 Lysine 9 Trimethylation and Heterochromatin Protein HP1-α.

Authors:  Rajarshi Chakrabarti; Sulagna Sanyal; Amit Ghosh; Kaushik Bhar; Chandrima Das; Anirban Siddhanta
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

8.  The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex.

Authors:  Elisabeth Finkbeiner; Markus Haindl; Stefan Muller
Journal:  EMBO J       Date:  2011-02-15       Impact factor: 11.598

Review 9.  Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.

Authors:  Luca Federici; Brunangelo Falini
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

10.  The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis.

Authors:  Barbara Herkert; Anne Dwertmann; Steffi Herold; Mona Abed; Jean-Francois Naud; Florian Finkernagel; Gregory S Harms; Amir Orian; Michael Wanzel; Martin Eilers
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.